VNS therapy in clinical practice in children with refractory epilepsy.
OBJECTIVE
To study the efficacy, tolerability and safety of the vagus nerve stimulation (VNS) therapy in clinical practice, in 16 children and adolescents with refractory epilepsy.


METHODS
We assessed the efficacy of VNS therapy, retrospectively by comparing seizure frequency, duration and severity at the time of most recent follow up (av: 24.9 months) to that in the 4 weeks prior to VNS surgery. Changes in quality of life, sleep and behaviour at last review was compared with that prior to VNS. Adverse effects elicited by specific questioning, spontaneous reporting and clinical examination are described.


RESULTS
Vagus nerve stimulation resulted in a >50% reduction in seizure frequency in 62.5% of children with 25% achieving a >90% reduction. Vagus nerve stimulation was well tolerated in all but one of our cohort, with no serious side-effects.


CONCLUSIONS
Our results support its role as one of the options in intractable childhood epilepsy.
Nagarajan
L
L
Department of Neurology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia. lakshmi.nagarajan@health.wa.gov.au
Walsh
P
P
Gregory
P
P
Lee
M
M
D000293:Adolescent; D002648:Child; D002653:Child Behavior Disorders / Q000209:etiology / Q000503:physiopathology; D002675:Child, Preschool; D004599:Electric Stimulation Therapy / Q000009:adverse effects*; D004827:Epilepsy / Q000503:physiopathology* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011788:Quality of Life; D012189:Retrospective Studies; D012720:Severity of Illness Index; D012893:Sleep Wake Disorders / Q000209:etiology / Q000503:physiopathology; D013997:Time Factors; D014630:Vagus Nerve / Q000503:physiopathology*